Kunle Odunsi, MD, PhD, and his colleagues at Roswell Park Cancer Institute, have been awarded a $900,000 research grant from the Ovarian Cancer Research Fund to collaborate on the development of an ovarian cancer vaccine. The researchers have made a therapeutic vaccine that trains the immune system to recognize and attack NY-ESO-1, a new protein that ovarian cancer cells sometimes display on their surface.
The Miami Breast Cancer Conference presented Larry Norton, MD, Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center, with its annual Award of Excellence. Dr. Norton was recognized for his research on the basic biology of cancer, the mathematics of tumor causation and growth, and the development of approaches to better diagnosis, prevention, and drug treatment of the disease.
Roswell Park has also appointed two new physicians in the expanding drug-development program in the Department of Medicine: Wen Wee Ma, MBBS, will treat patients with gastrointestinal cancers; and Grace K. Dy, MD, will treat patients with lung cancer.
The W.M. Keck Foundation has awarded researchers from City of Hope and the California Institute of Technology with a three-year, $1.5 million grant to continue a collaborative study investigating the molecular mechanisms underlying lymphoma and developing targeted, less toxic treatments for the disease based on short interfering RNA (siRNA) technology. The W. M. Keck foundation previously funded the first stage of the study in 2006 with a one-year, $450,000 pilot grant.
Michael P. Lisanti, MD, PhD, Professor of Biology at Jefferson Medical College of Thomas Jefferson University and the Kimmel Cancer Center, has been appointed Director of the newly established Jefferson Stem Cell Biology and Regenerative Medicine Center.© 2008 Lippincott Williams & Wilkins, Inc.
More on ONCOLOGY-TIMES.com...